Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Fourth breakthrough designation for Janssen’s Imbruvica

Janssen’s Imbruvica has picked up a fourth breakthrough designation as well as Orphan status from US regulators as a treatment for chronic graft-versus-host-disease (cGVHD).

Go to Source

Leave a Reply

News

Osteoporosis: Potential new drug target uncovered

A new study finds that targeting the body’s aging-related cells maintains and increases bone formation and improves bone mass and strength in aging mice. Powered by WPeMatico

more >

Multiple sclerosis: Are we close to a cure?

Discoveries and breakthroughs in multiple sclerosis research are building momentum, but just how close are we to finding a cure? We investigate. Powered by WPeMatico

more >

Reversing brain death: Far-fetched or feasible?

Ira Pastor, CEO of Bioquark, Inc., speaks to MNT about his team’s controversial plans to restore life to people who have been declared brain dead. Powered by WPeMatico

more >

Peanut allergy could be cured with probiotics

The vast majority of children in a large clinical trial continued to tolerate peanuts for 4 years after it had ended, new research shows. Powered by WPeMatico

more >

‘Accelerated approval’ drugs: How well are they studied?

When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and Drug Administration (FDA) has special programs available to… Powered by WPeMatico

more >

Prostate cancer: Study identifies earlier clinical trial endpoint that can be used to indicate effectiveness of new treatments

Scientists say they have validated a “surrogate endpoint” – a reliable statistical shortcut in a clinical trial – that could accelerate testing of new adjuvant therapies aimed at reducing deaths from… Powered by WPeMatico

more >